Advanced search
Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 35, 2018 - Issue 2
Submit an article Journal homepage
260
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Influence of a dosing-time on toxicities induced by docetaxel, cisplatin and 5-fluorouracil in patients with oral squamous cell carcinoma; a cross-over pilot study

Yoshiyuki TsuchiyaDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan;Oral and Maxillofacial Surgery, Tochigi Cancer Center, Tochigi, Japan
,
Kentaro UshijimaDivision of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2637-3916
ORCID Icon,
Tadahide NoguchiDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan
,
Naruo OkadaDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan
,
Jun-ichi HayasakaDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan
,
Yoshinori JinbuDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan
,
Hitoshi AndoDepartment of Cellular and Molecular Function Analysis, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan
,
Yoshiyuki MoriDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan
,
Mikio KusamaDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan;Oral and Maxillofacial Surgery, International University of Health and Welfare Hospital, Tochigi, Japan
&
Akio FujimuraDivision of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan
 show all
Pages 289-294 | Published online: 16 Nov 2017

References

  • Ahn JS, Cho SH, Kim OK, Lee JK, Yang DH, Kim YK, Lee JJ, Lim SC, Kim HJ, Chung WK, et al. 2007. The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer. Cancer Res Treat. 39:93–98.
  • Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R. 2006. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN). Anticancer Res. 26:585–90.
  • Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, et al. 2011. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 29:4189–98.
  • Bjarnason GA, Jordan R. 2000. Circadian variation of cell proliferation and cell cycle protein expression in man: Clinical implications. Prog Cell Cycle Res. 4:193–206.
  • Boughattas NA, Lévi F, Fournier C, Hecquet B, Lemaigre G, Roulon A, Mathé G, Reinberg A. 1990. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice. J Pharmacol Exp Ther. 255:672–79.
  • Buchi KN, Moore JG, Hrushesky WJ, Sothern RB, Rubin NH. 1991. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology. 101:410–15.
  • Falcone A, Allegrini G, Antonuzzo A, Brunetti I, Pfanner E, Lencioni M, Masi G, Danesi R, Del Tacca M, Conte P. 1999. Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery. Oncology. 57:195–201.
  • Granda TG, Filipski E, D’Attino RM, Vrignaud P, Anjo A, Bissery MC, Lévi F. 2001. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination. Cancer Res. 61:1996–2001.
  • Harris BE, Song R, Soong SJ, Diasio RB. 1990. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res. 50:197–201.
  • Harris BE, Song RL, He YJ, Soong SJ, Diasio RB. 1988. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy. Biochem Pharmacol. 37:4759–62.
  • Hashiguchi T, Nasu M, Hashimoto T, Kuniyasu T, Inoue H, Sakai N, Ouchi K, Amano T, Isayama F, Tomita N, et al. 2014. Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer. Mol Clin Oncol. 2:719–24.
  • Hrushesky WJ. 1983. The clinical application of chronobiology to oncology. Am J Anat. 168:519–42.
  • Kobayashi M, To H, Tokue A, Fujimura A, Kobayashi E. 2001. Cisplatin-induced vomiting depends on circadian timing. Chronobiol Int. 18:851–63.
  • Kobayashi M, To H, Yuzawa M, Hakamata Y, Higuchi S, Tokue A, Fujimura A, Kobayashi E. 2000. Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats. J Pharm Pharmacol. 52:1233–37.
  • Lévi F, Zidani R, Misset JL. 1997. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet. 350:681–86.
  • Meta-Analysis Group In Cancer. 1998. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors. J Clin Oncol. 16:3537–41.
  • Obi-Ioka Y, Ushijima K, Kusama M, Ishikawa-Kobayashi E, Fujimura A. 2013. Involvement of Wee1 in the circadian rhythm-dependent intestinal damage induced by docetaxel. J Pharmacol Exp Ther. 347:242–48.
  • Orr WC. 2005. Gastrointestinal physiology. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders. p. 283–91.
  • Roemeling RV, Christiansen NP, Hrushesky WJ. 1985. Lack of antiemetic effect of high-dose metoclopramide. J Clin Oncol. 3:1273–76.
  • Strojan P, Grašič Kuhar C, Žumer B, Kadivec M, Karner K, Fajdiga I, Jančar B, Gale N, Poljak M, Kocjan BJ, et al. 2014. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. Head Neck. 36:1555–61.
  • Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, François E, Bissery MC, Lévi F. 1998. Docetaxel chronopharmacology in mice. Cancer Res. 58:3896–904.
  • TAX 324 Study Group. 2007. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 357:1705–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.